The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis
NCT05078749 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2021-10-14
Summary
Systemic Sclerosis (Ssc) is a rare, systemic autoimmune disease characterized by skin fibrosis and vasculopathy. In addition to the skin, it is a heterogeneous disease that affects multiple organs, including the musculoskeletal, cardiac, pulmonary, and gastrointestinal systems. Patients may experience many symptoms such as pain, fatigue, dyspnea, impaired hand function, dry mouth, and difficulty sleeping. As a result of these symptoms, these patients may experience a decrease in activities of daily living, physical activity level and quality of life, while psychological problems such as anxiety and depression may increase. In addition to medical treatment, rehabilitation programs for the patient are an important part of treatment to eliminate or reduce these symptoms and their consequences.
Many problems such as time and resource constraints, transportation problems prevent access and compliance with the rehabilitation program. Also; For the coronavirus disease 2019 (COVID-19) epidemic that emerged in Wuhan, China in 2019, many countries have implemented many practices such as social distance, mandatory quarantine and transportation restrictions in order to better control the spread of the virus. Many people with SSc are at risk of serious complications from COVID-19 if infected due to lung involvement (\>40% have interstitial lung disease) and widespread use of immunosuppressant drugs. Most countries have recommended that people with medical conditions such as SSc undergo strict isolation during the COVID-19 pandemic. As a result, patients' access to the rehabilitation program became more difficult in this process. In addition, social isolation due to the COVID-19 outbreak may increase physical inactivity and cause complications that may develop accordingly.
When the literature was examined, no studies were found showing the effect of telerehabilitation program on anxiety depression, physical activity, sleep, fatigue and quality of life in patients with SSc.
Conditions
Interventions
- OTHER
-
Exercise training group
A regular advanced exercise program will be given and followed.
- OTHER
-
Control training group
Basic exercises will be given at the beginning and will do the same exercises
Sponsors & Collaborators
-
Gazi University
lead OTHER
Principal Investigators
-
Deran OSKAY, Prof · Gazi University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2021-12-01
- Completion
- 2022-10-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Exercise in Patients With Systemic Sclerosis
NCT03058887 ·Status: COMPLETED ·Phase: NA
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
NCT07182981 ·Status: RECRUITING
-
Chester Step Test: is It Effective in Scleroderma Patients?
NCT06859567 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
NCT01858259 ·Status: UNKNOWN
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Implementation of a Biological Sample Collection in Systemic Sclerosis Patients
NCT04986514 ·Status: WITHDRAWN
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
Evaluation of Muscle Involvement in Systemic Sclerosis
NCT06051773 ·Status: RECRUITING
-
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
NCT06297096 ·Status: RECRUITING ·Phase: PHASE3
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
NCT05273138 ·Status: RECRUITING
-
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
NCT06546540 ·Status: RECRUITING ·Phase: PHASE4
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF
NCT06758947 ·Status: COMPLETED ·Phase: PHASE3
-
NVC Test in Order to Assess Pathological Changes in Family Members of Patient Diagnosed With SSc
NCT02795221 ·Status: UNKNOWN
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
NCT04588714 ·Status: COMPLETED ·Phase: NA
-
Taking Charge of Systemic Sclerosis
NCT02494401 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035 ·Status: RECRUITING
-
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED